[Analysis of neuromuscular blocking drugs and sugammadex expenses, one year after its introduction into routine clinical practice]

Ann Fr Anesth Reanim. 2011 Oct;30(10):758-9. doi: 10.1016/j.annfar.2011.06.013. Epub 2011 Aug 4.
[Article in French]
No abstract available

Publication types

  • Letter

MeSH terms

  • Anesthesia, General / economics
  • Cholinesterase Inhibitors / economics
  • Cost-Benefit Analysis
  • Drug Utilization
  • Humans
  • Neostigmine / economics
  • Neuromuscular Nondepolarizing Agents / antagonists & inhibitors
  • Neuromuscular Nondepolarizing Agents / economics*
  • Sugammadex
  • gamma-Cyclodextrins / economics*

Substances

  • Cholinesterase Inhibitors
  • Neuromuscular Nondepolarizing Agents
  • gamma-Cyclodextrins
  • Sugammadex
  • Neostigmine